Last reviewed · How we verify

ACL/FOR

Queen's University · FDA-approved active Small molecule

ACL/FOR is a medication that helps to prevent blood clots from forming in the heart.

ACL/FOR is a medication that helps to prevent blood clots from forming in the heart. Used for Prevention of stroke and systemic embolism in non-valvular atrial fibrillation.

At a glance

Generic nameACL/FOR
Also known asaclidinium/formoterol, Duaklir
SponsorQueen's University
Drug classFactor Xa inhibitor
TargetFactor Xa
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

ACL/FOR works by inhibiting the coagulation cascade, specifically targeting the factor Xa enzyme. This leads to a reduction in the formation of blood clots, which can cause strokes and other cardiovascular events.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results